Thyroid Gland Oncocytic Carcinoma
3 clinical trials · Condition
◉ Watch Thyroid Gland Oncocytic Carcinoma
| Record | Firm | Date |
|---|---|---|
| Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation (NCT06440850) | City of Hope Medical Center | 2024-07-15 |
| Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer (NCT03914300) | National Cancer Institute (NCI) | 2020-02-10 |
| Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery (NCT00381641) | National Cancer Institute (NCI) | 2006-08-29 |
Track Thyroid Gland Oncocytic Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.